Ftse Mib
33.629,21
0,00%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.226,07
0,35%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. USOTC Provectus Biopharmaceuticals Inc (QB) (PVCT) Provectus Biopharmaceuticals Inc (QB) (PVCT) Notizie

PVCT

Provectus Biopharmaceuti... (QB) (PVCT)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:PVCT
DataOraFonteTitoloSimboloCompagnia
29/02/202415:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
22/02/202415:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
14/11/202317:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/06/202315:46Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/06/202300:41Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
11/05/202321:19Edgar (US Regulatory)Annual Report to Security Holders (ars)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
11/05/202320:42Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/202322:53Edgar (US Regulatory)Statement of Ownership (sc 13g)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
01/05/202319:59Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/202320:43Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/03/202315:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
12/12/202214:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/10/202219:30Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
29/03/202222:05Edgar (US Regulatory)Annual Report (10-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
25/11/202019:09Edgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
09/05/201922:50Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/201721:11Edgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
21/04/201719:58Edgar (US Regulatory)(25-NSE)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
20/04/201723:17Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
17/04/201723:18Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
30/03/201712:05Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
16/03/201721:17Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
06/03/201712:16Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
31/01/201712:23Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(4) (424b4)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
30/01/201712:01Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
26/01/201723:16Edgar (US Regulatory)Securities Registration Statement (s-1/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
05/10/201623:26Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
26/08/201612:04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
28/07/201622:49Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
13/05/201622:09Edgar (US Regulatory)Tender Offer Statement by Issuer (sc To-i)USOTC:PVCTProvectus Biopharmaceuticals Inc (QB)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:USOTC:PVCT

La tua Cronologia

BIT
ISP
Intesa Sanpaolo
BIT
UCG
Unicredit
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
ENI
Eni
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
SPM
Saipem
BIT
SRG
Snam
BIT
TEN
Tenaris
BIT
TRN
Terna Trasmissione Elett...
BIT
IVG
Iveco Group NV
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network